Recombinant adenovirus mediated hVEGF165 gene transfer promotes recovery of hematopoiesis in post-BMT mice.
- Author:
Zhao-Dong ZHONG
1
;
Yong YOU
;
Ling-Bo LIU
;
Ping ZOU
;
Zhi-Chao CHEN
;
Shi-Ang HUANG
Author Information
1. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Publication Type:Journal Article
- MeSH:
Adenoviridae;
genetics;
Animals;
Bone Marrow Transplantation;
methods;
Female;
Gene Expression;
Gene Transfer Techniques;
Genetic Vectors;
genetics;
Green Fluorescent Proteins;
genetics;
Hematopoiesis;
physiology;
Mice;
Mice, Inbred BALB C;
RNA, Messenger;
genetics;
metabolism;
Recombinant Fusion Proteins;
genetics;
Reverse Transcriptase Polymerase Chain Reaction;
Vascular Endothelial Growth Factor A;
blood;
genetics;
physiology
- From:
Journal of Experimental Hematology
2005;13(4):669-672
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the effects of vascular endothelial growth factor (VEGF) on the recovery of hematopoiesis in post-BMT mice, the recombinant adenovirus Ad-EGFP/hVEGF(165) was injected into syngeneic BMT BALB/c mice via the tail vein. At day 10, 20, 30 after BMT, the in vivo expression of hVEGF(165) was measured. At the same different time points, the numbers of WBC, Plt, RBC in peripheral blood and MNC in bone marrow were counted. By the way, the bone marrow MNCs at day 30 post-BMT were used for further CFU-S assay. The results indicated that a long-term expression of hVEGF(165) in plasma and different organs was successfully mediated by recombinant adenovirus. At each time point of post-BMT, the numbers of WBC, Plt, RBC as well as bone marrow MNC observed in the group treated with recombinant adenovirus Ad-EGFP/hVEGF(165) were lower than those of the normal control group, but were higher than those in other testing groups (P < 0.05). The number of CFU-S (21.4 +/- 2.67) formed by bone marrow MNC at day 30 after BMT reached to the normal level (19.50 +/- 2.46) (P > 0.05), which was much higher than that in other groups (P < 0.05). It is concluded that hVEGF(165) gene transfer mediated by recombinant adenovirus plays a role of promoting the recovery of hematopoiesis in post-BMT mice.